Jones Kevin, Snead O Carter, Boyd Jennifer, Go Cristina
The Division of Neurology, Department of Pediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada.
The Division of Neurology, Department of Pediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada
J Child Neurol. 2015 Apr;30(5):595-600. doi: 10.1177/0883073814533148. Epub 2014 Jun 25.
The Child Neurology Society/American Academy of Neurology practice parameter has recommended adrenocorticotropic hormone or vigabatrin in the short-term treatment of infantile spasms. When vigabatrin is unavailable or ineffective and adrenocorticotropic hormone is not a treatment option because of the prohibitive cost, other forms of corticosteroids have been considered in the treatment of infantile spasms. This retrospective study reviewed the Hospital for Sick Children's experience with the short-term effectiveness of prednisolone versus adrenocorticotropic hormone in patients with infantile spasms who have failed vigabatrin. The results showed that while adrenocorticotropic hormone was more likely to lead to short-term spasm freedom, there was no difference in the likelihood of longer-term spasm resolution without relapse. These findings can guide clinicians in the treatment of infantile spasms post vigabatrin failure.
儿童神经病学会/美国神经病学学会的实践参数推荐促肾上腺皮质激素或氨己烯酸用于婴儿痉挛症的短期治疗。当无法获得氨己烯酸或其无效,且由于成本过高促肾上腺皮质激素不是一种治疗选择时,其他形式的皮质类固醇已被考虑用于婴儿痉挛症的治疗。这项回顾性研究回顾了病童医院在氨己烯酸治疗失败的婴儿痉挛症患者中使用泼尼松龙与促肾上腺皮质激素的短期疗效经验。结果显示,虽然促肾上腺皮质激素更有可能导致短期痉挛缓解,但在长期痉挛缓解且无复发的可能性方面没有差异。这些发现可为临床医生在氨己烯酸治疗失败后治疗婴儿痉挛症提供指导。